INCOME STATEMENT
Cohance Lifesciences Ltd.
BSE
Jun 03, 11:41
1024.95
+1.50 (+ 0.15%)
Volume
10870
Prev. Close
1023.45
Open Price
1022.40
Bid Price(Qty.)
1021.80 (5)
Offer Pr.(Qty.)
1025.50 (9)
NSE
Jun 03, 11:29
1017.30
-5.20 ( -0.51%)
Volume
41274
Prev. Close
1022.50
Open Price
1034.70
Bid Price(Qty.)
1017.00 (10)
Offer Pr.(Qty.)
1018.00 (7)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE03QK01018
|
Market Cap. ( ₹ in Cr. )
|
25896.89
|
P/BV
|
13.09
|
Book Value ( ₹ )
|
77.71
|
|
BSE Code
|
543064
|
52 Week High/Low ( ₹ )
|
1360/598
|
FV/ML
|
1/1
|
P/E(X)
|
96.68
|
|
NSE Code
|
COHANCEEQ
|
Book Closure
|
09/08/2024
|
EPS ( ₹ )
|
10.52
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1009.49 | 1320.86 | 1307.01 | 995.46 | 817.28 |
| Other Operating Revenues | 15.51 | 9.22 | 13.21 | 14.25 | 16.51 |
| Total Operating Revenues | 1024.99 | 1330.08 | 1320.22 | 1009.72 | 833.79 |
| | | | | | |
| Other Income | 55.09 | 44.55 | 187.79 | 14.24 | 18.12 |
| Total Revenue | 1080.09 | 1374.63 | 1508.01 | 1023.96 | 851.91 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 248.38 | 421.36 | 459.46 | 310.32 | 240.24 |
| Operating And Direct Expenses | 127.78 | 170.87 | 173.19 | 122.73 | 105.75 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 53.88 | -20.94 | -60.35 | -8.37 | -11.05 |
| Employee Benefit Expenses | 126.88 | 100.84 | 100.48 | 87.29 | 73.72 |
| Finance Costs | 7.43 | 5.39 | 6.23 | 9.14 | 21.81 |
| Depreciation And Amortisation Expenses | 48.79 | 42.84 | 39.10 | 31.64 | 23.86 |
| Other Expenses | 58.17 | 74.87 | 67.46 | 57.23 | 39.98 |
| Total Expenses | 671.31 | 795.24 | 785.56 | 609.98 | 494.32 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 408.77 | 579.39 | 722.45 | 413.98 | 357.59 |
| | | | | | |
| Profit/Loss Before Tax | 408.77 | 579.39 | 722.45 | 413.98 | 357.59 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 98.14 | 144.63 | 157.63 | 101.54 | 88.81 |
| Deferred Tax | 6.59 | 4.34 | 6.72 | 3.62 | -1.30 |
| Tax For Earlier Years | -0.78 | -2.17 | 0.00 | 0.18 | 0.00 |
| Total Tax Expenses | 103.96 | 146.79 | 164.35 | 105.33 | 87.51 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 304.82 | 432.60 | 558.10 | 308.65 | 270.08 |
| | | | | | |
| Profit/Loss From Continuing Operations | 304.82 | 432.60 | 558.10 | 308.65 | 270.08 |
| | | | | | |
| Profit/Loss For The Period | 304.82 | 432.60 | 558.10 | 308.65 | 270.08 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 11.97 | 16.99 | 21.92 | 12.12 | 21.22 |
| Diluted EPS (Rs.) | 11.97 | 16.99 | 21.92 | 12.12 | 21.22 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 203.65 | 101.83 | 25.46 | 63.64 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 13.08 |
| Equity Dividend Rate (%) | 0.00 | 600.00 | 500.00 | 200.00 | 500.00 |